E. Hawkins

发表

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.

M. Birnbaum, K. Hoehn, J. Brozinick, 2007, Cell metabolism.

Disruption of Cortical Actin in Skeletal Muscle Demonstrates an Essential Role of the Cytoskeleton in Glucose Transporter 4 Translocation in Insulin-sensitive Tissues*

A. Strawbridge, J. S. Elmendorf, J. Brozinick, 2004, Journal of Biological Chemistry.

Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl Transferase.

J. Weidner, J. Brozinick, V. Reynolds, 2016, Journal of medicinal chemistry.

Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis.

J. Lockwood, J. Andrews, K. Kikly, 2013, American journal of physiology. Endocrinology and metabolism.

A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.

J. Brozinick, E. Hawkins, W. Bensch, 2005, Molecular endocrinology.

Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands.

A. R. Miller, J. Brozinick, C. Montrose‐Rafizadeh, 2006, Bioorganic & medicinal chemistry letters.

Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3.

R. Campbell, P. Iversen, M. Clay, 2004, Journal of medicinal chemistry.

Galactose oxidation in liver.

E. Hawkins, W. W. Wells, N. J. Rancour, 1979, Archives of biochemistry and biophysics.

The development of potent and selective bisarylmaleimide GSK3 inhibitors.

R. Campbell, B. Anderson, T. Engler, 2005, Bioorganic & medicinal chemistry letters.

Molecular cloning and functional expression of an insect high-affinity Na+-dependent glutamate transporter.

E. Hawkins, H. McLean, S. Caveney, 1997, European journal of biochemistry.

FGF-21 as a novel metabolic regulator.

J. Gromada, G. Sandusky, F. Mehrbod, 2005, The Journal of clinical investigation.

A Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with a Unique in Vitro Profile and Potent Glucose and Lipid Effects in Rodent Models of Type 2 Diabetes and Dyslipidemia

Joseph T. Brozinick, Alan M. Warshawsky, J. Brozinick, 2005 .

A Predominant Role of Acyl-CoA:monoacylglycerol Acyltransferase-2 in Dietary Fat Absorption Implicated by Tissue Distribution, Subcellular Localization, and Up-regulation by High Fat Diet*

J. Brozinick, Yuguang Shi, Jingsong Cao, 2004, Journal of Biological Chemistry.

Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet

J. Brozinick, K. Grove, E. Hawkins, 2012, International Journal of Obesity.

2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents.

J. Brozinick, C. Montrose‐Rafizadeh, C. Lamas, 2005, Bioorganic & medicinal chemistry letters.

Tetrahydroisoquinoline PPARgamma agonists: design of novel, highly selective non-TZD antihyperglycemic agents.

V. Devanarayan, J. Brozinick, C. Montrose‐Rafizadeh, 2006, Bioorganic & medicinal chemistry letters.